25 June 2024
The Russian pharmaceutical company Geropharm has dispatched a substantial shipment of insulin to Venezuela by sea, as confirmed by the Russian Ambassador to the Bolivarian Republic, Sergei Melik-Bagdasarov.
Last July, Geropharm shipped a batch of genetically engineered human insulin with both short and medium duration of action to Venezuela. The shipment included 1.1 million packages and syringe pens.
Melik-Bagdasarov noted that work is underway in the country to produce insulin using Russian technology. “For five years, we have been implementing a joint program with the Venezuelan Ministry of Health to supply insulin from our Russian company Geropharm, which in the future plans to launch a project here to build a production line for Venezuelan insulin using Russian technology,” he said.
Print06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
From January to August 2024, Russia’s medicinal product production totaled 530.7 billion rubles
27 September 2024
The government has expanded medicine sales in villages without pharmacies
27 September 2024
FDA issues draft guidance to help industry conduct global cancer clinical trials
26 September 2024
Optimizing Patient Support Through Effective Information Governance: Balancing Risks and Rewards
26 September 2024